ストックスクリーナーアプリを入手
1,064.29
2.12%
-23.09
アフターアワーズ：
1065.00
0.71
+0.07%
Lilly Eli Co (LLY) 最新ニュース
Whittier Trust Co. of Nevada Inc. Buys 2,524 Shares of Eli Lilly and Company $LLY - MarketBeat
Whittier Trust Co. Purchases 6,224 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Kanawha Capital Management LLC - MarketBeat
First Citizens Bank & Trust Co. Purchases 9,121 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly Shares Face Pressure as Key Drug Approval Timeline Shifts - AD HOC NEWS
3 Growth Stocks to Invest $1,000 in Right Now - The Motley Fool
Should You Dump Eli Lilly's Shares After This Setback? - The Motley Fool
The Truth About Eli Lilly (NYSEreplacing with LPLA): Why Everyone Is Suddenly Watching This Stock - AD HOC NEWS
Eli Lilly stock slips as obesity-drug headlines pile up ahead of next week - TechStock²
Guggenheim Reduces PT on Eli Lilly and Company (LLY) to $1,161, Reiterates 'Buy' Rating - Finviz
Eli Lilly and Company $LLY Shares Sold by Symphony Financial Ltd. Co. - MarketBeat
Mn Services Vermogensbeheer B.V. Has $233.24 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Dash Acquisitions Inc. Raises Stake in Eli Lilly and Company $LLY - MarketBeat
Jennison Associates LLC Has $3.20 Billion Holdings in Eli Lilly and Company $LLY - MarketBeat
BAM Wealth Management LLC Invests $1.09 Million in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly Shares: Market Experts Maintain Bullish Outlook Despite Recent Weakness - AD HOC NEWS
Should You Forget Eli Lilly and Buy These Unstoppable Stocks Instead? - Finviz
Here's How Eli Lilly's Oncology Drugs Are Poised Ahead of Q4 Earnings - The Globe and Mail
How the CEOs of AI leader Nvidia and drug giant Lilly drove a groundbreaking collaboration - The Business Journals
Bernstein Sees Eli Lilly Stock (LLY) Hitting $1,300 Per Share - TipRanks
Lockheed Martin Investment Management Co. Sells 27,400 Shares of Eli Lilly and Company $LLY - MarketBeat
Vantage Investment Partners LLC Has $39.54 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Spear Holdings RSC Ltd Reduces Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
ELI LILLY & CO (NYSE:LLY) Offers a Durable Dividend with Strong Growth and Financial Health - Chartmill
What obesity drugmakers see next in the market: More pills, easier access and drug combinations - CNBC
Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 - Finviz
Cipla Explores Semaglutide Generics Market Entry, Partners with Eli Lilly for Mounjaro Launch - scanx.trade
Eli Lilly and Company $LLY Shares Purchased by Envestnet Portfolio Solutions Inc. - MarketBeat
iA Global Asset Management Inc. Raises Stake in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Strategic Pipeline Developments Amid Market Volatility - AD HOC NEWS
Llamas Are Big Pharma’s Secret Weapon to Find New Drugs - Bloomberg
Eli Lilly’s Strategic Expansion: Pipeline Progress and Financial Outlook - AD HOC NEWS
Nvidia CEO to Lilly CEO: You Were Running Around the Forest … - Dealbreaker
Eli Lilly (LLY) Shines Amid Healthcare Sector's Underperformance - GuruFocus
Eli Lilly and Co's Options Frenzy: What You Need to Know - Benzinga
Vest Financial LLC Buys 2,178 Shares of Eli Lilly and Company $LLY - MarketBeat
Biocom Announces Powerhouse Keynote Panel Featuring Heads of Discovery and Research & Development from AbbVie, Amgen and Eli Lilly at 2026 Global Partnering & Investor Conference - BioSpace
Bey Douglas LLC Reduces Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly’s Oncology Ambitions Gain Momentum with Key FDA Designation - AD HOC NEWS
Nvidia CEO to Lilly CEO: You were running around the forest … - MedCity News
Eli Lilly and Company (NYSE:LLY) Stock Price Up 3.6%Time to Buy? - MarketBeat
Vital Signs: Unwrapping J&J's $100 billion ambition - FirstWord Pharma
Why Eli Lilly (LLY) Stock Is Up Today - Finviz
Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine - FinancialContent
Eli Lilly’s Oncology Pipeline Gains Momentum with Key Regulatory Designation - AD HOC NEWS
Stock Yards Bank & Trust Co. Acquires 1,197 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly: Buy Ahead Of Its Earnings Day (Preview) (NYSE:LLY) - Seeking Alpha
First-movers respond to biopharma herding into hot targets - Endpoints News
Rakuten Investment Management Inc. Makes New Investment in Eli Lilly and Company $LLY - MarketBeat
Migdal Insurance & Financial Holdings Ltd. Has $137.37 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Joel Isaacson & Co. LLC Acquires 3,976 Shares of Eli Lilly and Company $LLY - MarketBeat
Recludix Tackling Inflammatory Diseases with Backing From Eli Lilly - sdbj.com
Middleton & Co. Inc. MA Has $9.24 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Dynasty Wealth Management LLC Sells 3,206 Shares of Eli Lilly and Company $LLY - MarketBeat
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years - Sahm
Eli Lilly Faces Regulatory Delay as Key Drug Approval Pushed to 2026 - AD HOC NEWS
Bernstein Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,300 - 富途资讯
Abivax CEO Dismisses Rumors of Eli Lilly (LLY) Takeover as ‘Noise’ - TipRanks
Eli Lilly (LLY) Denies Acquisition Talks with Abivax (ABVX) - GuruFocus
Guggenheim Lowers Eli Lilly and Company (NYSE:LLY) Price Target to $1,161.00 - MarketBeat
Bernstein reiterates Outperform rating on Eli Lilly stock with $1,300 price target - Investing.com
JPM26: After a Tough 2025, Biohaven Is Gearing Up To Challenge Goliath—Lilly - BioSpace
New GCGR agonists disclosed in Eli Lilly patent - BioWorld MedTech
Abivax CEO dismisses 'noise' around rumored Eli Lilly bid - Reuters
Guggenheim Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Cuts Target Price to $1,161 - Futubull
0.76%
0.92%
大文字化:
|
ボリューム (24 時間):